Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Members of the Prostate Cancer Roundtable have received a letter from the Agency for Healthcare Research and Quality (AHRQ) addressing issues raised by the Roundtable members about the draft USPSTF recommendations on use of the PSA test in screening for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing | 1 Comment »
According to a media release we received yesterday, a new paper in the British Journal of Nutrition suggests that “walnuts may help to prevent prostate cancer risk.” … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Prevention, risk, walnut | 1 Comment »
For our US-based readers … It appears that Rep. Kucinich’s statements on his web site (reported on this web site a few days ago) are something of a political simplification of reality. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, USPSTF | 1 Comment »
A recent media release from the Radiological Society of North America (RSNA) is headed, “Preoperative MRU may reduce risk of nerve damage in prostate cancer surgeries” … and this is absolutely true. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: endorectal, MRI, outcome, plan, surgery | 1 Comment »
According to data just reported in The Lancet, some men with low-volume, low-risk prostate cancer may be able to delay progression of their disease if treated only with the 5α-reductase inhibitor dutasteride (Avodart®). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: dutasteride, low risk, Prevention, progression | 5 Comments »
According to an announcement on the web site of Congressmen Dennis Kucinich late yesterday, HHS Secretary Kathleen Sebelius has agreed to overule the draft recommendation issued by the U.S. Preventive Services Task Force (USPSTF) related to the use of PSA testing as a means to detect prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, rfisk, screening, testing | 9 Comments »
According to a media release issued late yesterday by the American Urological Association, Governor Christie has signed legislation in New Jersey that asks “the Congress of the United States to seek the withdrawal of the United States Preventative Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups.” … READ MORE …
Filed under: Diagnosis, Risk | 12 Comments »
The January 2012 issue of Oncology contains an open access, full-text article on the future sequencing of the recently approved and potentially new drugs that are or should soon be available for the treatment of advanced prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: advanced, drugs, new, sequencing | 1 Comment »
Two “pro” and “con” commentaries appeared on line this week in the Journal of Urology under the heading “Focal therapy will become standard treatment for localized prostate cancer.” .. READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: con, focal therapy, outcome, pro | 1 Comment »
Apparently, earlier this week, Congressmen Runyan and Baca (the co-chairmen of the Congressional Prostate Cancer Task Force) sent a letter to Secretary Sebelius about prostate cancer screening. … READ MORE …
Filed under: Uncategorized | 3 Comments »
From a health economics point of view, prostate cancer costs a lot of money every year — because a lot of men get diagnosed and treated. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, cost, cost-effectiveness | 3 Comments »
The issue of whether some urology practices are investing in equipment capable of delivering intensity-modulated radiation therapy (IMRT) with financial motives is back on the front burner again. … READ MORE …
Filed under: Uncategorized | Tagged: IMRT, motive, profit, radiation therapy, self-referral | 4 Comments »
What is the best type of treatment to offer a man after primary and (perhaps) appropriate secondary forms of treatment leave him with a rising PSA? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: androgen, deprivation, PAD, peripheral | 7 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site